Literature DB >> 15995524

Codetection of measles virus and tumor necrosis factor-alpha mRNA in otosclerotic stapes footplates.

Tamás Karosi1, József Kónya, László Z Szabó, József Pytel, József Jóri, Anita Szalmás, István Sziklai.   

Abstract

HYPOTHESIS: Otosclerosis is a disease of unknown etiology causing conductive or sensorineural hearing loss. Persistent measles virus infection of the otic capsule is considered to be one of the etiologic factors in otosclerosis.
BACKGROUND: Determinants of measles virus infection and reactive inflammation were studied in otosclerosis. The presence of measles virus was shown in otosclerotic patients by reverse-transcription polymerase chain reaction (RT-PCR) amplification of the viral RNA. No report is available, however, on the types and features of paracrine cytokines in otosclerosis.
METHODS: Nucleic acid was extracted from stapes footplate samples of clinically otosclerotic patients. Measles virus nucleoprotein RNA was amplified by seminested RT-PCR. Tumor necrosis factor (TNF)-alpha mRNA expression was detected by RT-PCR in otosclerotic bone and was correlated with preoperative audiologic findings and measles virus positivity.
RESULTS: Among 154 clinically otosclerotic patients, 99 stapes footplate specimens contained measles virus RNA. TNF-alpha mRNA was detectable in 88 virus-positive and in 6 virus-negative stapes footplates. There was no detectable TNF-alpha mRNA expression in virus negative cases.
CONCLUSION: The etiologic role of measles virus in the pathogenesis of otosclerosis should be considered. Detection of TNF-alpha mRNA demonstrates activated osteoclast functions and inflammatory pathways in otosclerotic stapes footplates associated with measles virus presence. Virus-associated and virus-negative pathomechanisms of otosclerosis should be distinguished.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15995524     DOI: 10.1097/01.MLG.0000165462.35495.DF

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

Review 1.  Etiopathogenesis of otosclerosis.

Authors:  Tamás Karosi; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-09       Impact factor: 2.503

2.  No evidence for an association between persistent measles virus infection and otosclerosis among patients with otosclerosis in Japan.

Authors:  Noritaka Komune; Mitsuru Ohashi; Nozomu Matsumoto; Takashi Kimitsuki; Shizuo Komune; Yusuke Yanagi
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

3.  Osteoprotegerin expression and sensitivity in otosclerosis with different histological activity.

Authors:  Tamás Karosi; Péter Csomor; Anita Szalmás; József Kónya; Mihály Petkó; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-10-21       Impact factor: 2.503

Review 4.  Genetics of otosclerosis: finally catching up with other complex traits?

Authors:  Lisse J M Tavernier; Erik Fransen; Hanne Valgaeren; Guy Van Camp
Journal:  Hum Genet       Date:  2021-09-09       Impact factor: 4.132

Review 5.  Perspectives of pharmacological treatment in otosclerosis.

Authors:  Balázs Liktor; Zoltán Szekanecz; Tamás József Batta; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-29       Impact factor: 2.503

Review 6.  An overview of the etiology of otosclerosis.

Authors:  Konstantinos Markou; John Goudakos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

7.  Gene expression analysis of human otosclerotic stapedial footplates.

Authors:  Megan Ealy; Wenjie Chen; Gi-Yung Ryu; Jae-Geun Yoon; D Bradley Welling; Marlan Hansen; Anup Madan; Richard J H Smith
Journal:  Hear Res       Date:  2008-03-15       Impact factor: 3.208

8.  Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis.

Authors:  Małgorzata Potocka-Bakłażec; Monika Sakowicz-Burkiewicz; Jerzy Kuczkowski; Tadeusz Pawełczyk; Czesław Stankiewicz; Wojciech Sierszeń; Zbigniew Jankowski; Jacek Buczny
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-28       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.